What medications can be prescribed for depression and anxiety?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications for Depression and Anxiety

For most patients with depression and anxiety, selective serotonin reuptake inhibitors (SSRIs) should be considered first-line treatment, with sertraline being a particularly good option due to its efficacy in treating both conditions and favorable side effect profile. 1

First-Line Medications

SSRIs (Selective Serotonin Reuptake Inhibitors)

  • Sertraline (Zoloft): Effective for both depression and anxiety, with better efficacy for melancholia and psychomotor agitation compared to other SSRIs 1
  • Fluoxetine (Prozac): Longer half-life which can be beneficial for patients who occasionally miss doses; FDA approved for depression in children/adolescents aged 8 years or older 1
  • Paroxetine (Paxil): Effective for multiple anxiety disorders but has higher risk of discontinuation syndrome 1
  • Citalopram/Escitalopram (Celexa/Lexapro): May have fewer drug-drug interactions than other SSRIs; citalopram requires caution with doses exceeding 40 mg/day due to QT prolongation risk 1
  • Fluvoxamine: Effective for anxiety disorders but has greater potential for drug-drug interactions 1

SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)

  • Venlafaxine (Effexor): May be superior to fluoxetine for treating anxiety; has dose-dependent effects with more norepinephrine reuptake inhibition at higher doses 1, 2, 3
  • Duloxetine (Cymbalta): More balanced serotonin and norepinephrine reuptake inhibition; also approved for pain conditions which may benefit patients with comorbid pain 1, 3
  • Desvenlafaxine (Pristiq): Primary metabolite of venlafaxine with favorable drug-drug interaction profile 3

Second-Line or Adjunctive Medications

Benzodiazepines

  • Alprazolam (Xanax): Effective for short-term management of anxiety symptoms; indicated for generalized anxiety disorder and panic disorder 4
  • Caution: Risk of dependence and withdrawal; generally not recommended for long-term use or as monotherapy for depression 1, 5

Other Antidepressants

  • Mirtazapine: Faster onset of action than SSRIs; may be more effective than fluoxetine; beneficial for patients with insomnia due to sedative effects 1
  • Bupropion (Wellbutrin): Option for patients with depression and minimal anxiety; less sexual side effects than SSRIs 1
  • Trazodone: Often used at lower doses for insomnia in depressed patients; shows improvement in sleep scores compared to fluoxetine and venlafaxine 1

Prescribing Considerations

Dosing Strategy

  • Start with lower doses for anxiety disorders as SSRIs can initially increase anxiety symptoms 1
  • For mild to moderate anxiety, increase dose in small increments at 1-2 week intervals for shorter half-life SSRIs (sertraline, citalopram) and 3-4 week intervals for longer half-life SSRIs (fluoxetine) 1
  • Higher doses may be needed for certain anxiety disorders like OCD compared to depression 1

Special Populations

  • For children and adolescents with anxiety disorders, combination treatment (CBT plus SSRI) is suggested over monotherapy 1
  • No significant differences in efficacy of second-generation antidepressants based on age, sex, or race/ethnicity 1
  • For patients with treatment-resistant depression, switching to a different antidepressant (bupropion, sertraline, or venlafaxine) results in about 25% of patients becoming symptom-free 1

Important Precautions

  • Avoid combining SSRIs with MAOIs due to risk of serotonin syndrome 1, 6
  • Monitor for QT prolongation with citalopram, especially at doses exceeding 40 mg/day 1
  • Be aware of discontinuation syndromes, particularly with paroxetine, fluvoxamine, and sertraline 1
  • SSRIs vary in their potential for drug interactions through CYP450 enzyme system; citalopram/escitalopram may have fewer interactions 1
  • For patients with hepatic impairment, dosage adjustments are necessary, particularly with venlafaxine 2

Comorbid Conditions

Depression with Anxiety

  • Most second-generation antidepressants show similar efficacy for depression with anxiety symptoms 1
  • Venlafaxine may be superior to fluoxetine for patients with significant anxiety 1
  • Sertraline, fluoxetine, and paroxetine show similar efficacy in patients with anxious depression 7

Depression with Insomnia

  • Consider mirtazapine, trazodone, or nefazodone which may improve sleep 1
  • Escitalopram shows improvement in sleep scores over citalopram 1

Depression with Pain

  • Duloxetine and paroxetine have demonstrated efficacy for patients with depression and pain 1, 3

By selecting the appropriate medication based on symptom profile, comorbidities, and potential side effects, clinicians can optimize treatment outcomes for patients with depression and anxiety disorders.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.